Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples

Clinical Chemistry

Volumn 53, Issue 6, 2007, Pages 1153-1155

  Shangguan, Dihua ^a,c   Cao, Zehui Charles ^a,c   Li, Ying ^b,c   Tan, Weihong ^a,c  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; DNA; FLUORESCEIN ISOTHIOCYANATE; RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LYMPHOMA; CANCER CELL; CANCER CELL CULTURE; CELL DIFFERENTIATION; CHEMICAL LABELING; DIAGNOSTIC ACCURACY; DNA PROBE; EARLY DIAGNOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; MOLECULAR PROBE; MOLECULAR RECOGNITION; NUCLEOTIDE METABOLISM; RNA PROBE; SYSTEMATIC EVOLUTION OF LIGAND BY EXPONENTIAL ENRICHMENT; T CELL LEUKEMIA;

APTAMERS, NUCLEOTIDE; BONE MARROW CELLS; DNA PROBES; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, T-CELL, ACUTE; LYMPHOMA; LYMPHOMA, LARGE-CELL, DIFFUSE; MULTIPLE MYELOMA; RNA PROBES; SELEX APTAMER TECHNIQUE; TUMOR CELLS, CULTURED;

EID: 34249870129     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.083246     Document Type: Article

References (13)

1. Espina V, Geho D, Mehta AI, Petricoin EF III, Liotta LA, Rosenblatt KP. Pathology of the future: molecular profiling for targeted therapy. Cancer Invest 2005;23:36-46.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
3. Belov L, dela Vega O, dos Remedios CG, Mulligan SP, Christopherson R. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res 2001;61:4483-9.
4. Shangguan D, Li Y, Tang Z, Cao Z, Chen H, Mallikratchy P, et al. Aptamers evolved from live cells as effective molecular probes for cencer study. Proc Natl Acad Sci U S A 2006;103:11838-43.
5. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-10.
6. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990;346:818-22.
7. Breaker RR. Natural and engineered nucleic acids as tools to explore biology. Nature 2004;432:838-45.
8. Yang CJ, Jockusch S, Vicens M, Turro N, Tan W. Light-switching excimer probes for rapid protein monitoring in complex biological fluids. Proc Natl Acad Sci U S A 2005;102:17278-83.
9. Nutlu R, Li Y. In vitro selection of structure-switching signaling aptamers. Angew Chem Int Ed Engl 2005;44:1061-5.
10. Uu JW, Lu Y. Fast colorimetric sensing of adenosine and cocaine based on a general sensor design involving aptamers and nanoparticles. Angew Chem Int Ed Engl 2005;45:90-4.
11. Blank M, Weinschenk T, Priemer M, Schluesener H. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. J Biol Chem 2001;276:16464-8.
12. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A 2003;100:15416-21.
13. Wang C, Zhang M, Yang G, Zhang D, Ding H, Wang H, et al. Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment. J. Biotechnol 2003;102:15-22.